Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug ...
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
The FDA pulled Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in ...
Pfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, ...
The drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper reported, citing two ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug.
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, ...
Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to ...
Pharmaceutical company, Pfizer Inc. has agreed to settle more than 10,000 cases accusing the company of hiding the cancer ...
Financial details of accords not immediately available Users claim Pfizer, GSK knew heartburn drug posed cancer risks Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the ...
-- Pfizer has agreed to settle over 10,000 cases against its heartburn drug Zantac for allegedly hiding cancer-associated risks, Bloomberg reports, citing people familiar with the deal. -- The ...